Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott Christensen

Considerations for Pre-operative Therapy to Optimize Care of Women with HER2+ Breast CancerПодробнее

Adjuvant Therapy for Early-Stage HER2-Positive Breast CancerПодробнее

Neoadjuvant therapy with neratinib plus trastuzumab in locally advanced HER2-positive breast cancerПодробнее

Overview of Neoadjuvant Therapy in HER2+ Breast CancerПодробнее

Moving the Needle in ER-Positive/HER2-Negative Metastatic Breast Cancer: Exploring SERD Strategie...Подробнее

Strategies for Improving Neoadjuvant Therapy Decision-making for HER2+ Breast CancerПодробнее

HER2+ Early-Stage Breast Cancer: Peri-Operative TherapyПодробнее

New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. SchwartzbergПодробнее

Neoadjuvant Therapy for HER2+ Breast CancerПодробнее

HER-2+ Breast Cancer - RussellПодробнее

Refining Neoadjuvant Chemotherapy for HER2+ Breast CancerПодробнее

Neoadjuvant and Adjuvant Therapy for HER2-positive Breast CancerПодробнее

CompassHER2-pCR: de-escalation of neoadjuvant chemotherapy for breast cancerПодробнее

Next wave of successful drug therapy strategies in HER2-positive breast cancerПодробнее

Neoadjuvant treatment approach for HER2 positive breast cancerПодробнее

1 + 1 = 3. Combined Use of Anti-HER2 Agents in the Neoadjuvant SettingПодробнее

Neoadjuvant Treatment Strategies for HER2-Positive Breast CancerПодробнее

Dr. Pegram on Challenges in Neoadjuvant Treatment for HER2-Positive Breast CancerПодробнее

Dual HER2 blockade in patients with HER2-positive breast cancer after pCRПодробнее